Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIPAC in Gastric Peritoneal Metastasis
NCT07517419Phase 2Enrolling by invitation
- Sponsor
- The Chinese University of Hong Kong
- Start
- Oct 2021
- Primary completion
- Feb 2031
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, doxorubicin in gastric cancer (GC), peritoneal metastasis (PM), sponsored by The Chinese University of Hong Kong. Started Oct 2021; status: enrolling by invitation.
02
Drugs
cisplatindoxorubicin
03
Conditions
gastric cancer (GC)peritoneal metastasis (PM)
Beyond the preview
Go deeper on NCT07517419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07517419.